Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hong In Tong Golden Bile Liver Care Capsules is a Traditional Chinese Medicine (TCM) formulation, also known as Jin Dan Hu Gan Jiao Nang, utilized for the management of liver dysfunction and dyslipidemia. The product is manufactured by Guangzhou Hongren Pharmaceutical and has been evaluated in clinical settings by Guangzhou Eighth People's Hospital. Its composition typically includes pig bile powder, which provides natural bile acids that act as agonists for the farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor 1 (TGR5), thereby modulating bile acid homeostasis and lipid metabolism. Additionally, the formulation contains herbal extracts such as Bupleurum and Scutellaria, which exert hepatoprotective, anti-inflammatory, and antioxidant effects. The drug is primarily indicated for patients exhibiting abnormal liver enzyme levels and lipid profiles, with Phase 4 studies focusing on its ability to improve liver health and reduce systemic inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hong In Tong Golden Bile Liver Care Capsules.